A variety of factors may increase the risk of endometrial adenocarcinoma in women. Many of the factors are associated with endometrial hyperplasia, often due to estrogenic stimulation.
Parameter |
Finding |
Risk Increase |
obesity |
30 - 49 pounds |
3.0 |
|
>= 50 pounds |
10.0 |
parity |
nulliparity |
2.0 |
menopause |
late occurring |
2.4 |
|
hemorrhagic ("bloody") |
4.0 |
diabetes mellitus |
|
2.8 |
hypertension |
|
1.5 |
estrogen-related |
unopposed estrogen replacement |
4 to 8 |
|
tamoxifen |
6.4 (page 300) |
endometrial hyperplasia |
complex atypical hyperplasia |
29.0 |
Combination of a progestin with estrogen will reduce the hyperplastic influence of unopposed estrogen.
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology
ICD-10: ,